June 18, 2025 · Form 4 insider transaction
Malik Fady Ibraham bought 30,000 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 30 days after the transaction.
Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026.